Xylem (XYL) Liabilities and Shareholders Equity (2016 - 2025)
Xylem (XYL) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $17.6 billion in Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity rose 6.92% year-over-year to $17.6 billion; the TTM value through Dec 2025 reached $51.5 billion, down 19.84%, while the annual FY2025 figure was $17.6 billion, 6.92% up from the prior year.
- Liabilities and Shareholders Equity reached $17.6 billion in Q4 2025 per XYL's latest filing, up from $17.3 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $17.6 billion in Q4 2025 and bottomed at $7.9 billion in Q1 2023.
- Average Liabilities and Shareholders Equity over 5 years is $12.5 billion, with a median of $15.8 billion recorded in 2024.
- Peak YoY movement for Liabilities and Shareholders Equity: fell 6.78% in 2022, then skyrocketed 102.62% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.3 billion in 2021, then dropped by 3.91% to $8.0 billion in 2022, then soared by 102.62% to $16.1 billion in 2023, then grew by 2.36% to $16.5 billion in 2024, then increased by 6.92% to $17.6 billion in 2025.
- Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $17.6 billion in Q4 2025, $17.3 billion in Q3 2025, and $16.6 billion in Q1 2025.